Crystalline forms of a pharmaceutical compound
Described are crystalline forms of the pharmaceutical compound "[9S-(9α,10 ,12α)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester", as well as metho...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.12.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described are crystalline forms of the pharmaceutical compound "[9S-(9α,10 ,12α)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester", as well as methods for their use and preparation. |
---|---|
Bibliography: | Application Number: US20050597977 |